Literature DB >> 19095996

Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis.

R de Nooijer1, I Bot, J H von der Thüsen, M A Leeuwenburgh, H S Overkleeft, A O Kraaijeveld, R Dorland, P J van Santbrink, S H van Heiningen, M M Westra, P T Kovanen, J W Jukema, E E van der Wall, Th J C van Berkel, G P Shi, E A L Biessen.   

Abstract

OBJECTIVE: A dysbalance of proteases and their inhibitors is instrumental in remodeling of atherosclerotic plaques. One of the proteases implicated in matrix degradation is cathepsin-S (CatS). To address its role in advanced lesion composition, we generated chimeric LDLr(-/-) mice deficient in leukocyte CatS by transplantation with CatS(-/-)xLDLr(-/-) or with LDLr(-/-) bone marrow and administered a high-fat diet. METHODS AND
RESULTS: No difference in aortic root lesion size could be detected between CatS(+/+) and CatS(-/-) chimeras. However, leukocyte CatS deficiency markedly changed plaque morphology and led to a dramatic reduction in necrotic core area by 77% and an abundance of large foam cells. Plaques of CatS(-/-) chimeras contained 17% more macrophages, 62% less SMCs, and 33% less intimal collagen. The latter two could be explained by a reduced number of elastic lamina fractures. Moreover, macrophage apoptosis was reduced by 60% with CatS deficiency. In vitro, CatS was found to be involved in cholesterol metabolism and in macrophage apoptosis in a collagen and fibronectin matrix.
CONCLUSIONS: Leukocyte CatS deficiency results in considerably altered plaque morphology, with smaller necrotic cores, reduced apoptosis, and decreased SMC content and collagen deposition and may thus be critical in plaque stability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095996     DOI: 10.1161/ATVBAHA.108.181578

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  22 in total

1.  Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses.

Authors:  Veronica Herías; Erik A L Biessen; Cora Beckers; Dianne Delsing; Mengyang Liao; Mat J Daemen; Christine C T N Pham; Sylvia Heeneman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-13       Impact factor: 8.311

2.  Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.

Authors:  Yanwen Qin; Xu Cao; Jun Guo; Yaozhong Zhang; Lili Pan; Hongjia Zhang; Huihua Li; Chaoshu Tang; Jie Du; Guo-Ping Shi
Journal:  Cardiovasc Res       Date:  2012-08-07       Impact factor: 10.787

Review 3.  Cysteinyl cathepsins in cardiovascular diseases.

Authors:  Xian Zhang; Songyuan Luo; Minjie Wang; Guo-Ping Shi
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-01-09       Impact factor: 3.036

4.  Increased plasma cathepsin S and trombospondin-1 in patients with acute ST-segment elevation myocardial infarction.

Authors:  Rahel Befekadu; Kjeld Christiansen; Anders Larsson; Magnus Grenegård
Journal:  Cardiol J       Date:  2018-04-03       Impact factor: 2.737

Review 5.  Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.

Authors:  Yanwen Qin; Guo-Ping Shi
Journal:  Pharmacol Ther       Date:  2011-05-12       Impact factor: 12.310

6.  Cysteine Protease Cathepsins in Atherosclerosis and Abdominal Aortic Aneurysm.

Authors:  Sara Sjöberg; Guo-Ping Shi
Journal:  Clin Rev Bone Miner Metab       Date:  2011-06-18

7.  Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice.

Authors:  Andoria Tjondrokoesoemo; Tobias G Schips; Michelle A Sargent; Davy Vanhoutte; Onur Kanisicak; Vikram Prasad; Suh-Chin J Lin; Marjorie Maillet; Jeffery D Molkentin
Journal:  J Biol Chem       Date:  2016-03-10       Impact factor: 5.157

8.  Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ deletion promotes abdominal aortic aneurysms.

Authors:  Milton Hamblin; Lin Chang; Hengmin Zhang; Kun Yang; Jifeng Zhang; Y Eugene Chen
Journal:  J Vasc Surg       Date:  2010-07-13       Impact factor: 4.268

9.  Low-Cost Method to Monitor Patient Adherence to HIV Antiretroviral Therapy Using Multiplex Cathepsin Zymography.

Authors:  Manu O Platt; Denise Evans; Philip M Keegan; Lynne McNamara; Ivana K Parker; LaDeidra M Roberts; Alexander W Caulk; Rudolph L Gleason; Daniel Seifu; Wondwossen Amogne; Clement Penny
Journal:  Mol Biotechnol       Date:  2016-01       Impact factor: 2.695

10.  Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.

Authors:  Santhosh Kumar Vr; Murthy N Darisipudi; Stefanie Steiger; Satish Kumar Devarapu; Maia Tato; Onkar P Kukarni; Shrikant R Mulay; Dana Thomasova; Bastian Popper; Jana Demleitner; Gabriele Zuchtriegel; Christoph Reichel; Clemens D Cohen; Maja T Lindenmeyer; Helen Liapis; Solange Moll; Emma Reid; Alan W Stitt; Brigitte Schott; Sabine Gruner; Wolfgang Haap; Martin Ebeling; Guido Hartmann; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.